CD86 and neoplasm: This suppressed PI3Kγ signaling, reducing the expression of M2 markers (CD206 and IL-10) and increasing the expression of M1 markers (CD86 and TNF-α), which inhibited tumor growth by reprogramming TAMs in 4T1 and MC38 mouse models.